Research Article
Pharmacodynamic Evaluation of the Gexia Zhuyu Decoction in the Treatment of NAFLD and the Molecular Mechanism Underlying the TRPM4 Pathway Regulation
Figure 12
Comparison of liver miRNA-24 content expression at the three stages of NAFLD. (a) NAFL group. (b) NASH group. (c) Nonalcoholic fatty liver fibrosis. Compared with the control group, ; compared with the model group, ā.
(a) |
(b) |
(c) |